Brief: Kuros Biosciences appoints Ivan Cohen-Tanugi as CEO

Kuros Biosciences AG

13/04/2017 06:00

April 13 (Reuters) - Kuros Biosciences AG  KURN.S : 
    * Announces CEO succession 
    * Ivan Cohen-Tanugi has been appointed Chief Executive 
Officer with effect as of April 13, 2017 
 
Source text for Eikon:  ID:nTEN3psz3a  
Further company coverage:  KURN.S  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))